NCT06716255View on ClinicalTrials.gov

Comparison of Effects of Buffered and Enteric-coated Forms of Aspirin on Platelet Aggregation in Patients With Diabetes Mellitus and Chronic Coronary Syndrome

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

May 17, 2024

Study Completion Date

September 24, 2024

Conditions
Diabetes Mellitus Type 2Coronary Artery DiseasesAspirin Resistance
Trial Locations (1)

117292

University Clinical Hospital na V.V.Vinogradov (branch of RUDN university na Patrice Lumumba), Moscow

Sponsors

Lead Sponsor

Nizhpharm
All Listed Sponsors
collaborator

Federal Scientific Clinical Centre of Pediatric Hematology, Oncology and Immunology named after Dmitry Rogache

OTHER

lead

Nizhpharm

OTHER

NCT06716255 - Comparison of Effects of Buffered and Enteric-coated Forms of Aspirin on Platelet Aggregation in Patients With Diabetes Mellitus and Chronic Coronary Syndrome | Biotech Hunter | Biotech Hunter